Vigonvita Life Sciences

This early-stage study tested the safety and how the body handles a new drug, LV232, in 81 healthy Chinese volunteers. Participants received either the drug or a placebo to check for side effects and measure drug levels in the blood. The goal was to gather safety information, not…

This early-stage study tested the safety and how the body handles multiple doses of the experimental drug LV232 in 49 healthy Chinese volunteers. Participants received different doses of LV232 or a placebo to check for side effects and measure drug levels in the blood. Since this…

This study looked at how well two different versions of an experimental oral drug (deuterium deuremidevir) are absorbed by the body. It involved 18 healthy Chinese adults aged 18 to 45. Participants took each version once, and researchers measured drug levels in their blood to co…